ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: DeVita Says He’ll Go Along With Any NCAB Decision On Organ Site Program; Talbt New AACI President

February 26, 1982

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

Radiologists Dispute Holland On NMR

April 20, 1984

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

April 30, 2004

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

CTEP Drafts FDA Approval Guidelines

March 4, 1988